APA (7th ed.) Citation

Cazzaniga, M., Martinez Jañez, N., Kukielka-Budny, B., Ulanska, M., Bourgeois, H., Muñoz Mateu, M., . . . Freyer, G. (2021). 203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer. Annals of Oncology, 32, S447. https://doi.org/10.1016/j.annonc.2021.08.485

Chicago Style (17th ed.) Citation

Cazzaniga, M.E, et al. "203P Randomized Study of Single-agent Metronomic Versus Weekly Oral Vinorelbine (VNR) as First-line Chemotherapy in Patients with HR+/HER2- Advanced Breast Cancer." Annals of Oncology 32 (2021): S447. https://doi.org/10.1016/j.annonc.2021.08.485.

MLA (9th ed.) Citation

Cazzaniga, M.E, et al. "203P Randomized Study of Single-agent Metronomic Versus Weekly Oral Vinorelbine (VNR) as First-line Chemotherapy in Patients with HR+/HER2- Advanced Breast Cancer." Annals of Oncology, vol. 32, 2021, p. S447, https://doi.org/10.1016/j.annonc.2021.08.485.